145 related articles for article (PubMed ID: 38441574)
1. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients.
Zhao A; Guo D; Zhu M; Gao A; Li P; Fu A
Eur J Clin Pharmacol; 2024 Jun; 80(6):911-918. PubMed ID: 38441574
[TBL] [Abstract][Full Text] [Related]
2. Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
Dugué A; Bagheri H; Lapeyre-Mestre M; Tournamille JF; Sailler L; Dedieu G; Salvayre R; Thouvenot JP; Massip P; Montastruc JL
Eur J Clin Pharmacol; 2004 Jun; 60(4):285-92. PubMed ID: 15114428
[TBL] [Abstract][Full Text] [Related]
3. The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening.
Linares LA; Golomb BA; Jaojoco JA; Sikand H; Phillips PS
Curr Drug Saf; 2009 Sep; 4(3):181-7. PubMed ID: 19534642
[TBL] [Abstract][Full Text] [Related]
4. Statin Associated Muscular Adverse Effects.
Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
[TBL] [Abstract][Full Text] [Related]
5. [A study of incidence and clinical characteristics of adverse drug reactions in hospitalized patients.].
Esteban Jiménez Ó; Navarro Pemán C; González Rubio F; Lanuza Giménez FJ; Montesa Lou C
Rev Esp Salud Publica; 2017 Dec; 91():. PubMed ID: 29269726
[TBL] [Abstract][Full Text] [Related]
6. [Visits of patients with exertional rhabdomyolysis to the Emergency Department at Landspítali, The National University Hospital of Iceland in the years 2008-2012].
Halldorsson AB; Benedikz E; Olafsson I; Mogensen B
Laeknabladid; 2016 Mar; 102(3):131-5. PubMed ID: 26985591
[TBL] [Abstract][Full Text] [Related]
7. Muscle toxicity with statins.
Hedenmalm K; Alvan G; Ohagen P; Dahl ML
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
[TBL] [Abstract][Full Text] [Related]
8. Managing statin-induced muscle toxicity in a lipid clinic.
Blaier O; Lishner M; Elis A
J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
[TBL] [Abstract][Full Text] [Related]
9. Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis.
Li Y; Zhu Y; Zhong Q; Zhang X; Shu M; Wan C
Pediatr Infect Dis J; 2017 Aug; 36(8):720-725. PubMed ID: 28060046
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine.
Zou XJ; Jiang XQ; Tian DY
J Viral Hepat; 2011 Dec; 18(12):892-6. PubMed ID: 22093034
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants.
O'Connor AD; Padilla-Jones A; Gerkin RD; Levine M
J Med Toxicol; 2015 Jun; 11(2):195-200. PubMed ID: 25468315
[TBL] [Abstract][Full Text] [Related]
12. Drug-related deaths in hospital inpatients: A retrospective cohort study.
Montané E; Arellano AL; Sanz Y; Roca J; Farré M
Br J Clin Pharmacol; 2018 Mar; 84(3):542-552. PubMed ID: 29148077
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda.
Kuteesa J; Nasasira M; Kiguba R
Expert Opin Drug Saf; 2024 Jan; 23(1):129-136. PubMed ID: 37552628
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
[TBL] [Abstract][Full Text] [Related]
15. Potential drug-drug interactions and adverse drug reactions in dermatological inpatients.
Koch L; Kränke B; Aberer W
J Dtsch Dermatol Ges; 2016 Nov; 14(11):1122-1129. PubMed ID: 27879085
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical spectrum of rhabdomyolysis in general neurology: a retrospective cohort study.
Paternostro C; Gopp L; Tomschik M; Krenn M; Weng R; Bointner K; Jäger F; Zulehner G; Rath J; Berger T; Zimprich F; Cetin H
Neuromuscul Disord; 2021 Dec; 31(12):1227-1234. PubMed ID: 34711480
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for adverse drug reactions in older inpatients of geriatric wards at admission: Multicenter study.
Kojima T; Matsui T; Suzuki Y; Takeya Y; Tomita N; Kozaki K; Kuzuya M; Rakugi H; Arai H; Akishita M
Geriatr Gerontol Int; 2020 Feb; 20(2):144-149. PubMed ID: 31829506
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical characteristics and automatic monitoring of drug-induced arrhythmias in 167,546 inpatients.
Guo H; Li P; Guo D; Gao A; Zhao P; Fu A; Li C; Lu J
Eur J Clin Pharmacol; 2023 Jun; 79(6):759-765. PubMed ID: 37039873
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database.
Mendes D; Alves C; Loureiro M; Fonte A; Batel-Marques F
J Clin Pharm Ther; 2019 Feb; 44(1):54-61. PubMed ID: 30069891
[TBL] [Abstract][Full Text] [Related]
20. Relationship of creatine kinase elevation and acute kidney injury in pediatric trauma patients.
Talving P; Karamanos E; Skiada D; Lam L; Teixeira PG; Inaba K; Johnson J; Demetriades D
J Trauma Acute Care Surg; 2013 Mar; 74(3):912-6. PubMed ID: 23425757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
